p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma. - Wikidata - wikimedia - TriplyDB

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

http://www.wikidata.org/entity/Q37059778

about

ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis.Exosomes containing differential expression of microRNA and mRNA in osteosarcoma that can predict response to chemotherapy.The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma.Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?

P2860

Q33635341-B9FFEA52-B9E2-46CC-A315-B0FF739F5FCF Q43076889-53A50A05-E91A-4C99-9D87-2AC740007508 Q45768840-29976084-8177-485E-AD4B-492FA066CCF3 Q46036353-87FB5298-3906-476C-B0B4-650AC32920B9 Q47362802-6CD21DD3-0BEA-41E3-81F4-9CA830904C7A Q58700294-81D83B40-B14C-46DF-815D-5DE359EBF853 Q58761026-3C8429B1-20D5-4A12-BB64-35C4D13351A6

P2860

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

http://www.wikidata.org/entity/Q37059778

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

@en

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

@nl

type

label

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

@en

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

@nl

prefLabel

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

@en

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

@nl

P1433

Q37059778-06083F20-F59D-4DA9-B953-E49AB418732D

P1476

Q37059778-806E0FDB-4152-445B-BFF9-1AFD105E7123

P2093

Q37059778-559F8199-20E8-4305-9239-B310CD518B67

Q37059778-659AD76C-4662-4A51-A48D-152D7B18B41B

Q37059778-6B7B14AC-0804-4520-9D9A-3A39DF336166

Q37059778-6FA242C5-3268-4CE2-9113-71BC68B8DCFA

Q37059778-80BB5BC9-511E-498A-A587-100FDEA9C6F7

Q37059778-B240A629-15DE-4997-8EB6-EF15AFDE5E8C

Q37059778-D967BCB8-B377-427E-A86D-754C9B6464B9

P2860

Q37059778-027DA4C3-4822-42B5-A91E-1572CA348ABA

Q37059778-0DAB6E9A-0EC0-4D40-89D3-8A2E37A746EF

Q37059778-14FB9191-A9B5-4658-896C-3354487E1381

Q37059778-179D492E-1A5B-401F-9845-CCF0F022A733

Q37059778-1AFA3F51-DD9F-4443-82DE-940B82CD7DD9

Q37059778-2DEDE949-B50E-427D-85B0-1C379F07BAB4

Q37059778-36EFF4FD-7C86-4983-BB4E-9A52DD0D520C

Q37059778-3BB4BF2E-934E-423E-B9C0-00B316A39C2A

Q37059778-43AD6BDD-71F1-4829-92DB-1EB7EA37026D

Q37059778-43D7E177-D6B4-4E7E-B96B-F12F98B524F1

P304

Q37059778-BA13494B-12FD-4F53-A80D-3740865F53BC

P31

Q37059778-5E6F48C3-8FF0-43E8-854C-86A181BEA8C3

P356

Q37059778-FF06FE62-3281-493A-8BB6-C310EA377B8E

P407

Q37059778-EC690C89-97F3-46B9-9815-3FD1A045EF9A

P433

Q37059778-5228A367-A9E6-4F78-A49A-6A0365321BFC

P478

Q37059778-5EDA0A1A-B155-4A7E-A6CB-3D5170815ABC

P50

Q37059778-1DDF27A5-2159-4AC1-81F4-317C34F56D81

P577

Q37059778-529A31F1-ACBB-42DC-8270-D02F23AB768F

P698

Q37059778-F7E12C57-1644-4D88-B21E-1F4C1035483A

P921

Q37059778-D5D36794-51C9-4BFB-A017-D934B0E0223C

P932

Q37059778-3350C713-12A8-4AF5-9246-FF5370B850A9

P356

0008-5472.CAN-15-3189

P1433

Cancer Research

P1476

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma

@en

P2093

Aaron J Kelly

http://www.w3.org/2001/XMLSchema#string

Ching C Lau

http://www.w3.org/2001/XMLSchema#string

Donald A Barkauskas

http://www.w3.org/2001/XMLSchema#string

John M Hicks

http://www.w3.org/2001/XMLSchema#string

Manjula Nakka

http://www.w3.org/2001/XMLSchema#string

Mark Krailo

http://www.w3.org/2001/XMLSchema#string

Yiting Li

http://www.w3.org/2001/XMLSchema#string

P2860

A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.

Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions

RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.

Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer

One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

The sentinel within: exploiting the immune system for cancer biomarkers.

Autoantibody signatures in prostate cancer.

P304

4002-4011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-15-3189

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27197201

http://www.w3.org/2001/XMLSchema#string

P921

P932

4930684

http://www.w3.org/2001/XMLSchema#string